fluorodeoxyglucose f18 has been researched along with Left Ventricular Dysfunction in 175 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 36 (20.57) | 18.2507 |
2000's | 97 (55.43) | 29.6817 |
2010's | 36 (20.57) | 24.3611 |
2020's | 6 (3.43) | 2.80 |
Authors | Studies |
---|---|
Bartenstein, P; Fischer, M; Graner, FP; Ilhan, H; Lehner, S; Todica, A | 2 |
Beanlands, RSB; Bernick, J; Birnie, DH; Burwash, IG; Chow, BWJ; deKemp, RA; Garrard, L; Huang, W; McArdle, B; Nery, PB; Redpath, CJ; Santi, ND; Wells, GA; Wu, KY | 1 |
Li, W; Li, X; Mi, H; Tian, Y; Zhang, X; Zhao, M; Zhu, Z | 1 |
Jain, D | 1 |
Bashir, H; Bhargav, M; Dhir, S; Goel, A; Jatin, S; Kumar, V; Roy, CP; Yadav, M | 1 |
Araujo Filho, JA; Assuncao, AN; Bierrenbach, ALS; Bocchi, EA; Dantas, RN; de Lima, CR; Giorgi, MCP; Hajjar, LA; Kalil Filho, R; Mady, C; Meneguetti, JC; Parga Filho, JR; Salemi, VMC; Soares, J; Tavares de Melo, MD | 1 |
Beela, AS; Bézy, S; Claus, P; Coudyzer, W; Degtiarova, G; Duchenne, J; Gheysens, O; Nuyts, J; Pagourelias, ED; Rega, F; Turco, A; Ünlü, S; Voigt, JU; Vunckx, K | 1 |
Cuocolo, A; Diomiaiuti, TC; Duro, G; Giugliano, G; Imbriaco, M; Nappi, C; Nicolai, E; Pisani, A; Ponsiglione, A; Riccio, E; Spinelli, L; Trimarco, B | 1 |
Abdalla, DR; Bengel, FM; Cunha-Neto, E; de Lourdes Higuchi, M; Dias Romano, MM; Kelly da Silva, G; Lemos de Oliveira, LF; Malamut, C; Marin Neto, JA; Mejia, J; Schmidt, A; Simões, MV; Tanaka, DM; Thackeray, JT; Vieira de Carvalho, EE | 1 |
Amzalag, G; Frei, A; Namdar, M; Nkoulou, R; Noble, S; Priamo, J; Rager, O; Ratib, O | 1 |
Koyanagawa, K; Manabe, O; Naya, M; Oyama-Manabe, N; Tamaki, N | 1 |
Kramer, CM; Löffler, AI | 1 |
Fahad, F; Saad Shaukat, MH; Torosoff, M; Weinreb, D | 1 |
Bézy, S; Claus, P; Cvijic, M; Degtiarova, G; Duchenne, J; Gheysens, O; Nuyts, J; Pagourelias, ED; Rega, F; Turco, A; Ünlü, S; Voigt, JU; Vunckx, K | 1 |
Benetos, G; Benz, DC; Buechel, RR; Fuchs, TA; Gaemperli, O; Gebhard, C; Giannopoulos, AA; Gräni, C; Huang, W; Kaufmann, PA; Messerli, M; Pazhenkottil, AP; von Dahlen, AP; von Felten, E | 1 |
Brunken, RC; Cerqueira, MD; Flores, DR; Hachamovitch, R; Jaber, WA; Ling, LF; Marwick, TH | 1 |
Beanlands, RS; Chow, BJ; DaSilva, J; deKemp, RA; Dwivedi, G; Garrard, L; Ghosh, N; Guo, A; Liu, Y; Ruddy, TD | 1 |
Bartenstein, P; Becker, A; Cumming, P; Hacker, M; Haug, A; Hellweger, S; Laubender, RP; Lehner, S; Slomka, PJ; Sohn, HY; Uebleis, C; Van Kriekinge, SD | 1 |
Bartenstein, P; Estner, H; Germano, G; Hacker, M; Haug, A; Kääb, S; Lehner, S; Schüßler, F; Uebleis, C; Van Kriekinge, SD | 1 |
Athanasiadis, A; Bossone, E; Cimarelli, S; Citro, R; Cittadini, A; Erbel, R; Ferrara, F; Limongelli, G; Lyon, A; Meimoun, P; Omerovic, E; Parodi, G; Perrone Filardi, P; Salerno-Uriarte, JA; Schneider, B; Sechtem, U | 1 |
Bhattacharya, A; Mittal, BR; Raja, S; Rohit, MK; Santhosh, S | 1 |
Lu, M; Qiu, M; Schindler, TH; Shen, R; Tian, C; Tian, Y; Wei, H; Zhang, X; Zhao, SH | 1 |
Arakawa, J; Fujikawa, A; Kastushika, S; Nagai, T | 1 |
Bouchelouche, K; Bøtker, HE; Flyvbjerg, A; Harms, HJ; Iversen, P; Jorsal, A; Nielsen, R; Sørensen, J; Tolbod, L; Wiggers, H | 1 |
Beanlands, RS; Benard, F; Bernick, J; Chow, BJ; DaSilva, JN; Davies, RA; deKemp, RA; Duchesne, L; Freeman, M; Garrard, L; Gulenchyn, K; Guo, A; Haddad, H; Hendry, P; Humen, D; Lim, SP; Masters, R; Mc Ardle, B; Mielniczuk, L; Nichol, G; Racine, N; Ross, H; Ruddy, TD; Shukla, T; Wells, GA | 1 |
Ayer, A; Cariou, B; Charpentier, F; Dollet, L; Jagu, B; Joubert, M; Le May, C; Magré, J; Manrique, A; Marechal, X; Montaigne, D; Prieur, X; Staels, B; Tesse, A; Toumaniantz, G | 1 |
Candell-Riera, J; Esteves, FP; Faber, TL; Folks, RD; Garcia, EV; Ornelas, M; Santana, CA; Santana, LF; Sanyal, R; Soler-Peter, M; Verdes, L | 1 |
Bax, JJ; de Roos, A; Dibbets-Schneider, P; Kaandorp, TA; Lamb, HJ; Marsan, NA; Roes, SD; Stokkel, MP; van der Wall, EE; Westenberg, JJ | 1 |
Aktas, MK; Allen, D; Chuang, HH; Jaber, WA; Taylor, DO; Yamani, MH | 1 |
Beanlands, RS; Benard, F; D'Egidio, G; DaSilva, J; deKemp, R; Freeman, M; Garrard, L; Gulenchyn, KY; Guo, A; Hendry, P; Humen, D; Nichol, G; Racine, N; Ruddy, TD; Williams, KA | 1 |
Beller, GA; Budge, LP | 1 |
Blankstein, R; Buckley, O; Desai, A; Di Carli, M; Dorbala, S; Doyle, L; Kwong, R; Lakdawala, N; Padera, R | 1 |
Maddahi, J | 1 |
Eisner, RL; O'Donnell, RE; Patterson, RE; Sigman, SR | 1 |
Abraham, A; Beanlands, RS; Chow, B; DaSilva, J; Davies, RA; deKemp, RA; Duchesne, L; Garrard, L; Guo, A; Haddad, H; Nichol, G; Williams, KA | 1 |
Boer, C; Bosmans, JW; Diamant, M; Handoko, LM; Huisman, MC; Lammertsma, AA; Lubberink, M; Molthoff, CF; Ouwens, MD; van den Brom, CE; Vlasblom, R | 1 |
Budikova, M; Kaminek, M; Meluzin, J; Metelkova, I; Panovský, R; Richter, M | 1 |
Dudczak, R; Graf, S; Gyöngyösi, M; Karanikas, G; Khorsand, A; Maurer, G; Porenta, G; Schuster, E; Sochor, H | 1 |
Anselm, AH; Anselm, DD; Atkins, HL; Beanlands, RS; Burwash, IG; Dasilva, J; de Kemp, R; Glover, CA; Guo, A; Kelly, C; Renaud, J; Williams, KA | 1 |
Buechel, RR; Fiechter, M; Gaemperli, O; Ghadri, JR; Herzog, BA; Husmann, L; Kaufmann, PA; Küest, SM; Nkoulou, R; Pazhenkottil, AP; Wolfrum, M | 1 |
Chubuchny, V; Di Cecco, P; Emdin, M; Ferrannini, E; Guiducci, L; Iozzo, P; Knuuti, J; Lautamäki, R; Masi, S; Morales, MA; Neglia, D; Nuutila, P; Pardini, S; Porciello, C; Salvadori, PA; Sironi, AM | 1 |
Bhattacharya, A; Kashyap, R; Manohar, K; Mittal, BR; Raja, S; Rohit, MK; Singh, B | 1 |
Castro, P; Chiong, M; Concepción, R; Enríquez, A; García, L; Greig, D; Lavandero, S; Orellana, P; Quintana, JC; Rossel, V; Sepúlveda, L; Sepúlveda, P; Verdejo, H; Winter, JL | 1 |
Al-Shehri, H; Alghamdi, AA; Ali, I; Beanlands, RS; Chow, BJ; deKemp, RA; Dwivedi, G; Klein, R; Ruddy, TD; Scullion, A | 1 |
Fang, W; Wang, L; Yan, C; Zhao, S | 1 |
Fang, W; Guo, J; Wang, JF; Wang, L; Wang, YT; Wei, HX; Yang, MF | 1 |
Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; Valkema, R | 1 |
Arendrup, H; Bangsgaard, R; Carstensen, S; Freiberg, J; Hesse, B; Holm, S; Hove, JD; Kelbaek, H; Kofoed, KF; Rabøl, A | 1 |
Bax, JJ; Knuuti, J; Schelbert, HR | 1 |
Bax, J; Bertella, M; Bigi, R; Celegon, L; Cortigiani, L; Desideri, A; Suzzi, G; Zanco, P | 1 |
Beanlands, RS; Burns, RJ; Coates, G; deKemp, RA; Fallen, E; Freeman, M; Hendry, P; Iwanochko, RM; Kostuk, W; Lamy, A; Mickleborough, L; Nahmias, C; Nichol, G; Ruddy, TD | 1 |
Borges-Neto, S; Coleman, RE; Hanson, MW; Pagnanelli, RA; Turkington, T | 1 |
Candelpergher, G; Celegon, L; Chierichetti, F; Costa, A; Franceschini, M; Neri, L; Suzzi, G; Terlizzi, R; Vaccari, D; Zanco, P | 1 |
Ehara, S; Fukuda, D; Hirose, M; Kobayashi, Y; Nakamura, Y; Sakanoue, Y; Shimada, K; Takeuchi, K; Yamagishi, H; Yoshikawa, J; Yoshiyama, M | 1 |
Buchert, R; Freyhoff, J; Lübeck, M; Lund, CH; Lund, GK; Meinertz, T; Nienaber, CA; Schwaiger, M; Sheehan, FH | 1 |
Bax, JJ; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; Valkema, R; van Domburg, R; Vourvouri, EC | 1 |
Bax, JJ; Boersma, E; Kam, BL; Krenning, EP; Poldermans, D; Rambaldi, R; Reijs, AE; Rietveld, T; Roelandt, JR; Valkema, R | 1 |
Buecker, A; Buell, U; Kaiser, HJ; Krombach, GA; Kühl, HP; Lipke, CS; Nowak, B; Schaefer, WM | 1 |
Bax, JJ; Eersels, J; Knapp, FF; Poldermans, D; Sloof, GW; van Lingen, A | 1 |
Beets, AL; Knapp, FF; Murphy, AM; Sloof, GW; van Eck-Smit, BL; Verberne, HJ | 1 |
Bax, JJ; Boersma, E; Elhendy, A; Geleijnse, ML; Poldermans, D; Roelandt, JR; Schinkel, AF | 1 |
Bax, JJ; Bountioukos, M; Poldermans, D; Rambaldi, R; Roelandt, JR | 1 |
Borges-Neto, S; Bourque, JM; O'Connor, CM; Shaw, LK; Velazquez, EJ; Whellan, DJ | 1 |
Bax, JJ; Bountioukos, MA; Elhendy, A; Krenning, EP; Poldermans, D; Roelandt, JR; Schinkel, AF; Valkema, R; van Domburg, RT; Vourvouri, EC | 1 |
Al-Mohammad, A; Egred, M; Norton, M; Redpath, TW; Semple, SK; Waiter, GD; Walton, S; Welch, A | 1 |
Bax, JJ; Boersma, E; Elhendy, A; Krenning, EP; Maddahi, J; Poldermans, D; Roelandt, JR; Schinkel, A; Valkema, R; van der Wall, EE | 1 |
Hisada, K; Matsunari, I; Nakajima, K; Taki, J; Tonami, N | 1 |
Croisille, P; Janier, M; Liu, S; Revel, D; Roux, JP; Zhao, S | 1 |
Buechi, M; Kaufmann, PA; Knuesel, PR; Lüscher, TF; Nanz, D; Schwitter, J; von Schulthess, GK; Wyss, C | 1 |
Bax, JJ; Biagini, E; Bountioukos, M; Elhendy, A; Kertai, MD; Krenning, B; Krenning, EP; Poldermans, D; Rizzello, V; Roelandt, JR; Schinkel, AF; Valkema, R; Vourvouri, EC | 1 |
Ando, A; Hirai, M; Ishigaki, T; Isobe, S; Ito, K; Izawa, H; Murohara, T; Nanasato, M; Nonokawa, M; Sobue, T; Yokota, M | 1 |
Aramburú, I; Brugère, S; Chamorro, H; Coll, C; González, P; Humeres, P; Jofré, J; Kunstmann, S; López, H; Massardo, T; Ramírez, A; Redondo, F; Sierralta, P; Yovanovich, J | 1 |
André-Fouët, X; Comar, D; Croisille, P; Duisit, J; Fol, S; Janier, MF; Mazzadi, AN; Ovize, M | 1 |
Gropler, RJ; Soto, P | 1 |
Beanlands, R; Benard, F; Coates, G; deKemp, RA; Fallen, E; Hendry, P; Humen, D; Iwanochko, RM; Nichol, G; Racine, N; Ross, H; Ruddy, TD; Wells, G | 1 |
Buecker, A; Buell, U; Kaiser, HJ; Krombach, GA; Kühl, HP; Lipke, CS; Nowak, B; Reinartz, P; Schaefer, WM | 1 |
Hasegawa, S; Hatazawa, J; Hori, M; Kusuoka, H; Maruyama, K; Nishimura, T | 1 |
Brunken, RC; Griffin, BP; Kalahasti, V; Pu, M; Rodriguez, D; Thomas, JD; Underwood, D; Yang, H | 1 |
Breithardt, OA; Buell, U; Hanrath, P; Kaiser, HJ; Nowak, B; Reinartz, P; Schaefer, WM; Sinha, AM; Stellbrink, C | 1 |
Bonser, R; Camici, P; Dutka, D; Pagano, D; Pitt, M | 1 |
Assmus, B; Berner, U; Britten, M; Dimmeler, S; Döbert, N; Grünwald, F; Hamscho, N; Lehmann, R; Menzel, C; Schächinger, V; Zeiher, AM | 1 |
Bax, JJ; Biagini, E; Bountioukos, M; Krenning, BJ; Poldermans, D; Rizzello, V; Roelandt, JR; Schinkel, AF; Valkema, R; Vourvouri, EC | 1 |
Brunken, RC; Buda, T; Hoercher, K; McCarthy, PM; O'Neill, JO; Starling, RC; Young, JB | 1 |
Aramburu, I; Brugère, S; Chamorro, H; Coll, C; González, P; Humeres, P; Jofré, MJ; Massardo, T; Sierralta, P; Yovanovich, J | 1 |
Hisada, K; Kanayama, S; Matsudaira, M; Matsunari, I; Nakajima, K; Nekolla, SG; Taki, J; Tonami, N; Yoneyama, T | 2 |
Brogsitter, C; Burchert, W; Grüning, T; Körfer, R; Lindner, O; Weise, R; Wielepp, P | 1 |
Barthel, H; Kluge, R; Pankau, H; Sabri, O; Schauer, J; Seese, A; Seyfarth, HJ; Steinbach, J; Winkler, J; Wirtz, H | 1 |
Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; van der Wall, EE | 1 |
Kageyama, H; Katoh, C; Kuge, Y; Mabuchi, M; Morita, K; Noriyasu, K; Shiga, T; Tamaki, N; Tsukamoto, T; Yoshinaga, K | 1 |
Bax, JJ; Biagini, E; Poldermans, D; Rambaldi, R; Rizzello, V; Roelandt, JR; Valkema, R | 1 |
Bax, JJ; de Boer, J; Jager, PL; Mook, PH; Oudkerk, M; Slart, RH; van der Wall, EE; van Veldhuisen, DJ; Willemsen, AT | 1 |
Altiok, E; Buell, U; Hanrath, P; Hoffmann, R; Kaiser, HJ; Kühl, H; Nowak, B | 1 |
Arseniev, L; Drexler, H; Ganser, A; Hertenstein, B; Hofmann, M; Knapp, WH; Menke, A; Meyer, GP; Wollert, KC | 1 |
Bax, JJ; Biagini, E; Elhendy, A; Poldermans, D; Rizzello, V; Schinkel, AF; Schouten, O; Simoons, M; Valkema, R; van Domburg, RT | 1 |
Cuocolo, A | 1 |
Krause, BJ; Mau, J; Müller, HW; Poeppel, TD; Reinhardt, M; Strauer, BE; Vester, EG; Vosberg, H; Yong, M | 1 |
Duarte, PS; Farsky, PS; Gimenes, VM; Issa, M; Martins, LR; Paulista, PP; Petisco, AC; Piegas, LS; Sousa, JE | 1 |
Conway, EM; Flögel, U; Hermann, S; Jacoby, C; Keul, P; Levkau, B; Livieratos, L; Schäfers, KP; Schäfers, M; Schober, O; Schrader, J; Stegger, L | 1 |
Bax, JJ; Christen, AI; Cortigiani, L; Coscarelli, S; Desideri, A; Gregori, D; Komorovsky, R; Zanco, P | 1 |
Bax, JJ; Dierckx, RA; Jager, PL; Slart, RH; van der Wall, EE; van Veldhuisen, DJ | 1 |
Abdel-Latif, A; Al-Chekakie, MO; Blackstone, EH; Brunken, R; Lauer, MS; McCarthy, PM; Pothier, CE; Tarakji, KG | 1 |
Bax, JJ; Biagini, E; Elhendy, A; Krenning, EP; Poldermans, D; Rizzello, V; Schinkel, AF; Simoons, ML; Valkema, R; van Domburg, RT | 1 |
Bax, JJ; Blanksma, PK; Hisada, K; Kanayama, S; Matsunari, I; Nekolla, SG; Tonami, N; Visser, FC; Yoneyama, T | 1 |
Inoue, N; Inoue, T; Ishikawa, T; Kimura, K; Kobayashi, T; Matsumoto, K; Matsushita, K; Sumita, S; Takahashi, N; Uchino, K; Umemura, S | 1 |
Bax, JJ; de Boer, J; Dierckx, RA; Irwan, R; Jager, PL; Slart, RH; Sluiter, WJ; van der Wall, EE; van Veldhuisen, DJ | 1 |
Lee, JD; Nakano, A; Okazawa, H; Shirasaki, H; Ueda, T; Uzui, H; Yonekura, Y | 1 |
Correa, PL; de Azevedo, JC; Dohmann, HF; Felix, RC; Mesquita, CT; Mesquita, ET | 1 |
Agool, A; Bax, JJ; Dierckx, RA; Slart, RH; van Veldhuisen, DJ | 1 |
Sawada, SG | 1 |
Altenberger, J; Pirich, C; Rendl, G | 1 |
Bax, JJ; Bleeker, GB; Boersma, E; Dibbets-Schneider, P; Schalij, MJ; Steendijk, P; Stokkel, MP; van der Wall, EE; Ypenburg, C | 1 |
Bonser, RS; Camici, PG; Dutka, DP; Gathercole, D; Mongillo, M; Pagano, D; Pitt, M | 1 |
Bacharach, SL; Bateman, TM; Bax, JJ; Beanlands, R; Bengel, F; Bergmann, SR; Brunken, RC; Case, J; Delbeke, D; DiCarli, MF; Garcia, EV; Goldstein, RA; Gropler, RJ; Machac, J; Patterson, R; Schelbert, HR; Travin, M | 1 |
Camici, PG; John, AS; Leccisotti, L; Mongillo, M; Pennell, DJ | 1 |
Balogh, L; Czuriga, I; Edes, I; Galuska, L; Hunyadi, J; Kristóf, E | 1 |
Kanao, S; Kimura, T; Komeda, M; Marui, A; Tadamura, E; Togashi, K; Toma, M; Wu, YW; Yamamuro, M | 1 |
Reyes, E | 1 |
Kanao, S; Komeda, M; Marui, A; Tadamura, E; Tanabara, K; Togashi, K; Wu, YW; Yamamuro, M | 1 |
Beanlands, RS; Benard, F; deKemp, R; Freeman, M; Garrard, L; Gulenchyn, KY; Guo, A; Humen, D; Huszti, E; Iwanochko, RM; Lamy, A; Nichol, G; Racine, N; Ruddy, TD | 1 |
Biadi, O; Landoni, C; Lucignani, G; Mariani, M; Mariani, MA; Mengozzi, G; Palagi, C; Paolini, G; Vanoli, G; Zuccari, M | 1 |
Ling, LH; Pellikka, PA; Tei, C | 1 |
Biadi, O; Donatelli, F; Fazio, F; Landoni, C; Lucignani, G; Mariani, MA; Mengozzi, G; Palagi, C; Paolini, G; Vanoli, G | 1 |
Cook, SA; Fix, JS; Go, RT; James, KB; Lee, KS; MacIntyre, WJ; Marwick, TH; Sapp, SK; Thomas, JD | 1 |
Asgarzadie, F; Brunken, RC; Di Carli, MF; Laks, H; Maddahi, J; Phelps, ME; Schelbert, HR | 1 |
Calhoun, WB; Drane, WE; Mills, RM | 1 |
Baer, FM; de Vivie, ER; Deutsch, HJ; Erdmann, E; Horst, M; Schicha, H; Schneider, CA; Sechtem, U; Voth, E | 1 |
Bol, A; Gerber, BL; Labar, D; Melin, JA; Michel, C; Vanoverschelde, JL; Wijns, W | 1 |
Altehoefer, C; Buechin, P; Buell, U; Hanrath, P; Messmer, BJ; Sheehan, FH; Uebis, R; vom Dahl, J | 1 |
Bax, JJ; Huitink, JM; van Lingen, A; Visser, CA; Visser, FC | 1 |
Beanlands, RS; deKemp, RA; Johansen, H; Ruddy, TD; Smith, S | 1 |
Bax, JJ; Boersma, E; Cornel, JH; Elhendy, A; Fioretti, PM; Maat, AP; Roelandt, JR; van Lingen, A; Visser, FC | 1 |
Coma-Canella, I; García Velloso, MJ | 1 |
de Landsheere, CM; Degueldre, C; Kulbertus, HE; Mélon, PG; Peters, JL; Piérard, LA | 1 |
Haas, F; Haehnel, CJ; Martinoff, S; Meisner, H; Nekolla, S; Picker, W; Schwaiger, M | 1 |
Bax, JJ; Cornel, JH; Fioretti, PM; Krenning, EP; Poldermans, D; Rambaldi, R; Roelandt, JR; Valkema, R; van Lingen, A; Visser, CA; Visser, FC | 1 |
Udelson, JE | 1 |
Bacharach, SL; Bartlett, ML; Dilsizian, V; Kitsiou, AN; Miller-Davis, C; Srinivasan, G | 1 |
Bax, JJ; Cornel, JH; Poldermans, D; van der Wall, EE; van Eck-Smit, BL | 1 |
Bonser, RS; Camici, PG; Horton, R; Littler, WA; Pagano, D; Townend, JN | 1 |
Barton, HJ; Bergin, PJ; Berlangieri, SU; Esmore, DS; Kalff, V; Kelly, MJ; van Every, B | 1 |
Carstensen, S; Haunsø, S; Hesse, B; Holm, S; Hove, JD; Jensen, M; Kelbaek, H; Kofoed, KF | 1 |
Bonser, RS; Camici, PG; Fath-Ordoubadi, F; Keogh, BE; Marinho, NV; Pagano, D | 1 |
Blanksma, PK; Crijns, HJ; van den Heuvel, AF; van Veldhuisen, DJ | 1 |
Baer, FM; Erdmann, E; Gawlich, S; Horst, M; Schicha, H; Schneider, CA; Sechtem, U; Voth, E | 1 |
Bax, JJ; Cornel, JH; Elhendy, A; Fioretti, PM; Huitink, JM; Poldermans, D; Roelandt, JR; van Lingen, A; Visser, CA; Visser, FC | 1 |
Baer, FM; Crnac, J; Schmidt, M; Theissen, P | 1 |
Arrighi, JA; Bacharach, SL; Bonow, RO; Dilsizian, V; Marin-Neto, JA; Perrone-Filardi, P | 1 |
Beanlands, RS; deKemp, RA; Hendry, PJ; Masters, RG; Ruddy, TD; Woodend, K | 1 |
Bacharach, SL; Bartlett, ML; Dilsizian, V; Kitsiou, AN; Quyyumi, AA; Srinivasan, G; Summers, RM | 1 |
Lauer, MS; Lytle, BW; Marwick, TH; Secknus, MA; Williams, J; Zuchowski, C | 1 |
Campisi, R; Czernin, J; Hoh, CK; Moon, DH; Ohtake, T; Schelbert, HR; Schöder, H | 1 |
Di Credico, G; Fazio, F; Galli, L; Gilardi, MC; Grossi, A; Landoni, C; Lucignani, G; Paolini, G; Pelenghi, S; Rossetti, C; Zuccari, M | 1 |
Bax, JJ; Boersma, E; Elhendy, A; Fioretti, PM; Krenning, EP; Poldermans, D; Rambaldi, R; Roelandt, JR; Valkema, R; Vletter, WB | 1 |
Bax, JJ; Wijns, W | 1 |
Bartorelli, A; Fazio, F; Garraffa, G; Guazzi, M; Ippolito, M; Landoni, C; Lucignani, G; Pepi, M; Rossetti, C; Savi, A | 1 |
Blanksma, PK; Crijns, HJ; Siebelink, HM; Vaalburg, WM; van den Heuvel, AF; van der Wall, EE; van Gilst, WH; van Veldhuisen, DJ | 1 |
Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Rambaldi, R; Roelandt, JR; Valkema, R; Vletter, W | 1 |
Akioka, K; Muro, T; Takeuchi, K; Tani, T; Teragaki, M; Watanabe, H; Yamagishi, H; Yoshikawa, J | 1 |
Ababneh, AA; Akinboboye, O; Bergmann, SR; Epstein, S; Henriquez, J; Hickey, KT; Pinsky, D; Rohatgi, R | 1 |
Coleman, RE; DeGrado, TR; Hughes, GC; Landolfo, CK; Landolfo, KP; Lowe, JE; Yin, B | 1 |
Fang, W; Gao, R; Guo, S; Hu, S; Liu, XJ; Liu, Y; Shi, R; Tian, Y; Wu, Q; Zhang, X | 1 |
Bax, JJ; Blanksma, PK; Bol, A; Camici, PG; Gerber, BL; Janier, M; Knuuti, MJ; Melin, JA; Melon, P; Ordoubadi, FF; Vanoverschelde, JL; Wijns, W | 1 |
Bax, JJ; Borghetti, A; De Sutter, J; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; Valkema, R; Vourvouri, EC | 1 |
Beanlands, RS; deKemp, RA; Ruddy, TD; Vitale, GD; Williams, K | 1 |
Altiok, E; Büll, U; Hanrath, P; Heussen, N; Hoffmann, R; Kaiser, HJ; Kühl, H; Nowak, B | 1 |
DePuey, G; Dorbala, S; Li, VH; Narula, D; Steinberg, JS | 1 |
Allman, KC; Hachamovitch, R; Shaw, LJ; Udelson, JE | 1 |
Mari, C; Strauss, WH | 1 |
Segall, G | 1 |
Bax, JJ; Boersma, E; Elhendy, A; Poldermans, D; Roelandt, JR; Schinkel, AF; Sozzi, FB; Valkema, R; Vourvouri, EC | 1 |
Bax, JJ; Boersma, E; Camici, PG; Fath-Ordoubadi, F; Wijns, W | 1 |
Barkhausen, J; Brandt-Mainz, K; Freudenberg, L; Hunold, P; Knipp, S; Neumann, T; Vogt, FM | 1 |
18 review(s) available for fluorodeoxyglucose f18 and Left Ventricular Dysfunction
Article | Year |
---|---|
The role of multimodality imaging in takotsubo cardiomyopathy.
Topics: 3-Iodobenzylguanidine; Acute Coronary Syndrome; Cardiology; Cardiovascular Diseases; Echocardiography; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Magnetic Resonance Spectroscopy; Multimodal Imaging; Nuclear Medicine; Positron-Emission Tomography; Radionuclide Imaging; Radiopharmaceuticals; Takotsubo Cardiomyopathy; Ventricular Dysfunction, Left | 2019 |
Myocardial Viability Testing to Guide Coronary Revascularization.
Topics: Chronic Disease; Coronary Occlusion; Echocardiography, Stress; Fluorodeoxyglucose F18; Heart Failure; Humans; Magnetic Resonance Angiography; Myocardial Revascularization; Myocardial Stunning; Positron-Emission Tomography; Radiopharmaceuticals; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2018 |
Takotsubo cardiomyopathy: an integrated multi-imaging approach.
Topics: Algorithms; Coronary Angiography; Echocardiography; Echocardiography, Three-Dimensional; Electrocardiography; Fluorodeoxyglucose F18; Humans; Incidence; Magnetic Resonance Imaging; Myocardial Infarction; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Risk Factors; Takotsubo Cardiomyopathy; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2014 |
The need for standardisation of cardiac FDG PET imaging in the evaluation of myocardial viability in patients with chronic ischaemic left ventricular dysfunction.
Topics: Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Myocardium; Quality Control; Radiopharmaceuticals; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2002 |
[Myocardial positron emission tomography (PET) with fluorodeoxyglucose-18F].
Topics: Cardiomyopathy, Dilated; Coronary Disease; Data Collection; Fluorodeoxyglucose F18; Heart; Humans; Hypoglycemia; Image Processing, Computer-Assisted; Medical History Taking; Radiopharmaceuticals; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2002 |
Noninvasive evaluation of ischaemic heart disease: myocardial perfusion imaging or stress echocardiography?
Topics: Echocardiography, Stress; Fluorodeoxyglucose F18; Humans; Myocardial Ischemia; Myocardial Reperfusion; Perfusion; Radiopharmaceuticals; Recovery of Function; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2003 |
Radionuclide viability testing: should it affect treatment strategy in patients with cardiomyopathy and significant coronary artery disease?
Topics: Coronary Disease; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Myocardial Revascularization; Prospective Studies; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Myocardial viability assessment using nuclear imaging.
Topics: Cell Survival; Coronary Artery Disease; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Stunning; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Recent advances in cardiac positron emission tomography in the clinical management of the cardiac patient.
Topics: Coronary Artery Disease; Coronary Vessels; Fluorodeoxyglucose F18; Heart; Humans; Myocardium; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2004 |
Imaging techniques in nuclear cardiology for the assessment of myocardial viability.
Topics: Coronary Disease; Fluorodeoxyglucose F18; Humans; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Rubidium Radioisotopes; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2006 |
Positron emission tomography for assessment of viability.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Heart; Humans; Positron-Emission Tomography; Prognosis; Tissue Survival; Ventricular Dysfunction, Left | 2006 |
Assessment of myocardial viability in chronic left ventricular dysfunction.
Topics: Chronic Disease; Deoxyglucose; Dobutamine; Echocardiography; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Myocardial Stunning; Myocardium; Nitroglycerin; Thallium Radioisotopes; Tissue Survival; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1995 |
[Clinical usefulness of positron emission tomography (PET) in the evaluation of myocardial viability].
Topics: Coronary Disease; Fluorodeoxyglucose F18; Humans; Myocardial Contraction; Myocardial Infarction; Myocardial Revascularization; Myocardium; Oxygen Consumption; Oxygen Radioisotopes; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Water | 1997 |
Detection of myocardial viability with F-18-fluorodeoxyglucose and single photon emission computed tomography.
Topics: Cardiotonic Agents; Dobutamine; Fluorodeoxyglucose F18; Humans; Myocardium; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1997 |
[Myocardial tissue vitality: clinical relevance, pathophysiology and identification].
Topics: Coronary Circulation; Fluorodeoxyglucose F18; Glucose; Humans; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Predictive Value of Tests; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1998 |
Myocardial viability testing and impact of revascularization on prognosis in patients with coronary artery disease and left ventricular dysfunction: a meta-analysis.
Topics: Coronary Disease; Dobutamine; Echocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Linear Models; Male; Middle Aged; Myocardial Revascularization; Prognosis; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2002 |
Detection and characterization of hibernating myocardium.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Heart; Heart Function Tests; Humans; Myocardial Stunning; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Assessment of myocardial viability by positron emission tomography.
Topics: Fluorodeoxyglucose F18; Heart; Humans; Myocardial Ischemia; Myocardial Revascularization; Myocardium; Prognosis; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
41 trial(s) available for fluorodeoxyglucose f18 and Left Ventricular Dysfunction
Article | Year |
---|---|
Comparison of LVEF assessed by 2D echocardiography, gated blood pool SPECT, 99mTc tetrofosmin gated SPECT, and 18F-FDG gated PET with ERNV in patients with CAD and severe LV dysfunction.
Topics: Adult; Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Echocardiography; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Stroke Volume; Ventricular Dysfunction, Left | 2014 |
Heart failure patients with prediabetes and newly diagnosed diabetes display abnormalities in myocardial metabolism.
Topics: Aged; Cicatrix; Coronary Circulation; Diabetes Complications; Diabetes Mellitus, Type 2; Disease Progression; Echocardiography; Female; Fluorodeoxyglucose F18; Glucose; Glucose Tolerance Test; Heart; Heart Failure; Humans; Liraglutide; Male; Metabolic Syndrome; Middle Aged; Myocardium; Perfusion; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Postprandial Period; Prediabetic State; Ventricular Dysfunction, Left | 2018 |
Long-Term Follow-Up of Outcomes With F-18-Fluorodeoxyglucose Positron Emission Tomography Imaging-Assisted Management of Patients With Severe Left Ventricular Dysfunction Secondary to Coronary Disease.
Topics: Aged; Canada; Coronary Artery Disease; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Myocardium; Patient Readmission; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Factors; Severity of Illness Index; Time Factors; Tissue Survival; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2016 |
Increasing benefit from revascularization is associated with increasing amounts of myocardial hibernation: a substudy of the PARR-2 trial.
Topics: Aged; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Kidney; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Myocardial Stunning; Myocardium; Patient Readmission; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Proportional Hazards Models; Prospective Studies; Radiopharmaceuticals; Risk Assessment; Risk Factors; Stroke Volume; Time Factors; Tissue Survival; Treatment Outcome; Ventricular Dysfunction, Left | 2009 |
Long-term results of intracoronary bone marrow cell transplantation: the potential of gated sestamibi SPECT/FDG PET imaging to select patients with maximum benefit from cell therapy.
Topics: Aged; Biological Transport; Bone Marrow Transplantation; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Vessels; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Middle Aged; Myocardial Infarction; Patient Selection; Positron-Emission Tomography; Radioactive Tracers; Technetium Tc 99m Sestamibi; Time Factors; Treatment Outcome; Ventricular Dysfunction, Left | 2010 |
Low whole-body insulin sensitivity in patients with ischaemic heart disease is associated with impaired myocardial glucose uptake predictive of poor outcome after revascularisation.
Topics: Aged; Coronary Artery Bypass; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Humans; Insulin Resistance; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Treatment Outcome; Ventricular Dysfunction, Left | 2002 |
Positron emission tomography and recovery following revascularization (PARR-1): the importance of scar and the development of a prediction rule for the degree of recovery of left ventricular function.
Topics: Aged; Canada; Cicatrix; Cohort Studies; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Multivariate Analysis; Myocardial Revascularization; Predictive Value of Tests; Prospective Studies; Radionuclide Angiography; Radiopharmaceuticals; Recovery of Function; Severity of Illness Index; Statistics as Topic; Stroke Volume; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2002 |
Dobutamine-induced contractile reserve in stunned, hibernating, and scarred myocardium in patients with ischemic cardiomyopathy.
Topics: Dobutamine; Echocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardial Stunning; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Single-Blind Method; Stress, Physiological; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Feasibility and image quality of dual-isotope SPECT using 18F-FDG and (99m)Tc-tetrofosmin after acipimox administration.
Topics: Administration, Oral; Chronic Disease; Coronary Artery Disease; Echocardiography; Feasibility Studies; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Pyrazines; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Validation of an evaluation routine for left ventricular volumes, ejection fraction and wall motion from gated cardiac FDG PET: a comparison with cardiac magnetic resonance imaging.
Topics: Aged; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Stroke Volume; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2003 |
Effect of diabetes mellitus on myocardial 18F-FDG SPECT using acipimox for the assessment of myocardial viability.
Topics: Blood Glucose; Coronary Artery Disease; Diabetes Complications; Diabetes Mellitus; Diabetes Mellitus, Type 1; Diabetes Mellitus, Type 2; Fatty Acids, Nonesterified; Feasibility Studies; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Pyrazines; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2003 |
Characterization of dysfunctional myocardium by positron emission tomography and magnetic resonance: relation to functional outcome after revascularization.
Topics: Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Combined study with FDG PET and Tl SPECT in patients with idiopathic dilated cardiomyopathy.
Topics: Age Factors; Cardiomyopathy, Dilated; Diagnosis, Differential; Disease-Free Survival; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Myocardial Ischemia; Prognosis; Radiation-Protective Agents; Reproducibility of Results; Risk Assessment; Sensitivity and Specificity; Sex Factors; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
An assessment of wall motion, perfusion and glucose metabolism in recent myocardial infarction: a comparison in patients with and without revascularization.
Topics: Adult; Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Glucose; Heart Ventricles; Humans; Male; Middle Aged; Movement; Myocardial Infarction; Myocardial Revascularization; Myocardial Stunning; Radionuclide Imaging; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Thallium; Treatment Outcome; Ultrasonography; Ventricular Dysfunction, Left | 2003 |
Evaluation of outcome and cost-effectiveness using an FDG PET-guided approach to management of patients with coronary disease and severe left ventricular dysfunction (PARR-2): rationale, design, and methods.
Topics: Cost-Benefit Analysis; Fluorodeoxyglucose F18; Humans; Multicenter Studies as Topic; Myocardial Ischemia; Myocardial Revascularization; Randomized Controlled Trials as Topic; Research Design; Surgery, Computer-Assisted; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2003 |
Validation of QGS and 4D-MSPECT for quantification of left ventricular volumes and ejection fraction from gated 18F-FDG PET: comparison with cardiac MRI.
Topics: Aged; Aged, 80 and over; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Heart Ventricles; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging; Male; Middle Aged; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Statistics as Topic; Stroke Volume; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2004 |
Ischemic and viable myocardium in patients with non-Q-wave or Q-wave myocardial infarction and left ventricular dysfunction: a clinical study using positron emission tomography, echocardiography, and electrocardiography.
Topics: Case-Control Studies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Prognosis; Radiopharmaceuticals; Rubidium Radioisotopes; Stroke Volume; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2004 |
Comparison of regional myocardial blood flow and perfusion in dilated cardiomyopathy and left bundle branch block: role of wall thickening.
Topics: Adult; Aged; Arteries; Blood Flow Velocity; Bundle-Branch Block; Cardiomyopathy, Dilated; Coronary Circulation; Coronary Vessels; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Male; Middle Aged; Oxygen Radioisotopes; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ultrasonography; Ventricular Dysfunction, Left; Water | 2004 |
Transplantation of progenitor cells after reperfused acute myocardial infarction: evaluation of perfusion and myocardial viability with FDG-PET and thallium SPECT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Positron-Emission Tomography; Radiopharmaceuticals; Stem Cell Transplantation; Stents; Thallium; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
The predictive value of 201Tl rest-redistribution and 18F-fluorodeoxyglucose SPECT for wall motion recovery after recent reperfused myocardial infarction.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Prognosis; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; Sensitivity and Specificity; Single-Blind Method; Thallium; Thrombolytic Therapy; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
Electrocardiographic-gated dual-isotope simultaneous acquisition SPECT using 18F-FDG and 99mTc-sestamibi to assess myocardial viability and function in a single study.
Topics: Adult; Aged; Aged, 80 and over; Electrocardiography; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Humans; Image Enhancement; Male; Middle Aged; Myocardial Infarction; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2005 |
18F-FDG PET for detecting myocardial viability: validation of 3D data acquisition.
Topics: Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2005 |
Different mechanisms for changes in glucose uptake of the right and left ventricular myocardium in pulmonary hypertension.
Topics: Female; Fluorodeoxyglucose F18; Glucose; Heart Ventricles; Humans; Hypertension, Pulmonary; Male; Metabolic Clearance Rate; Middle Aged; Myocardium; Radionuclide Imaging; Radiopharmaceuticals; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right | 2005 |
Comparison of 99mTc-sestamibi/18FDG DISA SPECT with PET for the detection of viability in patients with coronary artery disease and left ventricular dysfunction.
Topics: Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Male; Middle Aged; Myocardial Stunning; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2005 |
Monitoring of bone marrow cell homing into the infarcted human myocardium.
Topics: Adult; Aged; Antigens, CD34; Bone Marrow Cells; Bone Marrow Transplantation; Cell Movement; Fluorodeoxyglucose F18; Humans; Leukocytes; Male; Middle Aged; Myocardial Infarction; Myocardium; Organ Specificity; Positron-Emission Tomography; Transplantation, Autologous; Ventricular Dysfunction, Left | 2005 |
Accuracy of cardiac PET imaging using post-injection transmission scan.
Topics: Adult; Aged; Aged, 80 and over; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Injections, Intravenous; Male; Middle Aged; Myocardial Infarction; Nitrogen Radioisotopes; Phantoms, Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Time Factors; Ventricular Dysfunction, Left | 2005 |
Impact of diabetes mellitus on prediction of clinical outcome after coronary revascularization by 18F-FDG SPECT in patients with ischemic left ventricular dysfunction.
Topics: Comorbidity; Coronary Artery Bypass; Diabetes Mellitus; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Netherlands; Outcome Assessment, Health Care; Prognosis; Radiopharmaceuticals; Risk Assessment; Risk Factors; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Effect of left ventricular function on diagnostic accuracy of FDG SPECT.
Topics: Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2006 |
Prediction of functional recovery after revascularization in patients with chronic ischaemic left ventricular dysfunction: head-to-head comparison between 99mTc-sestamibi/18F-FDG DISA SPECT and 13N-ammonia/ 18F-FDG PET.
Topics: Aged; Ammonium Chloride; Coronary Artery Bypass; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Nitrogen Radioisotopes; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Comparative assessment of 18F-fluorodeoxyglucose PET and 99mTc-tetrofosmin SPECT for the prediction of functional recovery in patients with reperfused acute myocardial infarction.
Topics: Aged; Aged, 80 and over; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2006 |
Nitrate administration increases blood flow in dysfunctional but viable myocardium, leading to improved assessment of myocardial viability: A PET study.
Topics: Aged; Blood Flow Velocity; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Nitrates; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Technetium; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left | 2006 |
[Effects of autologous bone marrow derived CD34+ stem cells on the left ventricular function following myocardial infarction].
Topics: Adult; Antigens, CD34; Bone Marrow Cells; Echocardiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Infarction; Pilot Projects; Positron-Emission Tomography; Radiopharmaceuticals; Stem Cell Transplantation; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2007 |
F-18-fluorodeoxyglucose positron emission tomography imaging-assisted management of patients with severe left ventricular dysfunction and suspected coronary disease: a randomized, controlled trial (PARR-2).
Topics: Aged; Coronary Disease; Death; Disease Management; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Positron-Emission Tomography; Survival Rate; Ventricular Dysfunction, Left | 2007 |
Predictive value of low dose dobutamine transesophageal echocardiography and fluorine-18 fluorodeoxyglucose positron emission tomography for recovery of regional left ventricular function after successful revascularization.
Topics: Adrenergic beta-Agonists; Deoxyglucose; Dobutamine; Echocardiography, Transesophageal; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Predictive Value of Tests; Prospective Studies; Sensitivity and Specificity; Time Factors; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left | 1996 |
Prediction of improvement of ventricular function after revascularization. 18F-fluorodeoxyglucose single-photon emission computed tomography vs low-dose dobutamine echocardiography.
Topics: Analysis of Variance; Cardiotonic Agents; Chi-Square Distribution; Coronary Artery Bypass; Deoxyglucose; Dobutamine; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Myocardial Revascularization; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1997 |
The limited role of myocardial fluorine-18 fluorodeoxyglucose imaging in candidates for cardiac transplantation: a planar imaging study.
Topics: Adult; Aged; Coronary Circulation; Female; Fluorodeoxyglucose F18; Heart; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1998 |
Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular
Topics: Blood Pressure; Cardiotonic Agents; Dobutamine; Echocardiography; Exercise Test; Fluorodeoxyglucose F18; Heart; Heart Rate; Humans; Male; Middle Aged; Myocardial Infarction; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1999 |
Prediction of functional recovery in patients with myocardial infarction after revascularization--comparison of low-dose dobutamine stress echocardiography with fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Aged; Cell Survival; Dobutamine; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Myocardium; Predictive Value of Tests; Prognosis; Sensitivity and Specificity; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 2001 |
Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
Topics: Aged; Coronary Angiography; Echocardiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Heart Aneurysm; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Prognosis; Radiopharmaceuticals; Survival Analysis; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2001 |
Positron emission tomography using(18)F-fluoro-deoxyglucose and euglycaemic hyperinsulinaemic glucose clamp: optimal criteria for the prediction of recovery of post-ischaemic left ventricular dysfunction. Results from the European Community Concerted Acti
Topics: Adult; Aged; Belgium; Blood Glucose; Coronary Disease; Female; Finland; Fluorodeoxyglucose F18; Follow-Up Studies; France; Glucose Clamp Technique; Humans; Hyperinsulinism; London; Male; Middle Aged; Myocardial Revascularization; Myocardium; Netherlands; Predictive Value of Tests; Preoperative Care; Prospective Studies; Recovery of Function; Stroke Volume; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2001 |
Accuracy of PET in predicting functional recovery after revascularisation in patients with chronic ischaemic dysfunction: head-to-head comparison between blood flow, glucose utilisation and water-perfusable tissue fraction.
Topics: Adult; Aged; Chronic Disease; Coronary Circulation; Coronary Vessels; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Oxygen Radioisotopes; Postoperative Period; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Stroke Volume; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left; Water | 2002 |
116 other study(ies) available for fluorodeoxyglucose f18 and Left Ventricular Dysfunction
Article | Year |
---|---|
Assessment of left ventricular function with gated myocardial perfusion SPECT and gated myocardial FDG PET in patients with left ventricular mechanical dyssynchrony.
Topics: Fluorodeoxyglucose F18; Humans; Myocardial Perfusion Imaging; Perfusion; Positron-Emission Tomography; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2023 |
Metabolic activity of the left and right atria are differentially altered in patients with atrial fibrillation and LV dysfunction.
Topics: Atrial Fibrillation; Fluorodeoxyglucose F18; Heart Atria; Humans; Myocardium; Ventricular Dysfunction, Left | 2022 |
Left ventricular mechanical dyssynchrony analzyed by Tc-99m sestamibi SPECT and F-18 FDG PET in patients with ischemic cardiomyopathy and the prognostic value.
Topics: Aged; Cardiomyopathies; Death, Sudden, Cardiac; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Risk Factors; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2020 |
Molecular imaging of tumor-specific markers and their expression in other organs.
Topics: Animals; Biomarkers, Tumor; Cardiology; Diastole; Fibroblasts; Fluorodeoxyglucose F18; Heart; Humans; Inflammation; Ligands; Molecular Imaging; Neoplasms; Nuclear Medicine; Regeneration; Systole; Ventricular Dysfunction, Left | 2021 |
Comparative Assessment of Revascularization Versus Drug Management in Coronary Artery Disease (CAD) Associated with Left Ventricular Dysfunction (EF < 40%) - A 12 Month Study with FDG PET and SPECT MPI Analyses.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Myocardial Revascularization; Positron-Emission Tomography; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2020 |
The assessment of left ventricular mechanical dyssynchrony from gated
Topics: Fluorodeoxyglucose F18; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2022 |
Decreased glycolytic metabolism in non-compaction cardiomyopathy by 18F-fluoro-2-deoxyglucose positron emission tomography: new insights into pathophysiological mechanisms and clinical implications.
Topics: Adult; Analysis of Variance; Case-Control Studies; Cohort Studies; Female; Fluorodeoxyglucose F18; Glucose; Humans; Image Enhancement; Isolated Noncompaction of the Ventricular Myocardium; Male; Middle Aged; Multivariate Analysis; Positron-Emission Tomography; Prospective Studies; Severity of Illness Index; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2017 |
Papillary muscles contribute significantly more to left ventricular work in dilated hearts.
Topics: Animals; Cardiac-Gated Imaging Techniques; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Heart Rate; Papillary Muscles; Positron-Emission Tomography; Proof of Concept Study; Radiopharmaceuticals; Respiratory-Gated Imaging Techniques; Sheep; Sheep, Domestic; Stroke Volume; Tomography, X-Ray Computed; Ventricular Dysfunction, Left | 2019 |
Early Cardiac Involvement Affects Left Ventricular Longitudinal Function in Females Carrying α-Galactosidase A Mutation: Role of Hybrid Positron Emission Tomography and Magnetic Resonance Imaging and Speckle-Tracking Echocardiography.
Topics: Adult; Aged; alpha-Galactosidase; Biomarkers; Cardiac-Gated Imaging Techniques; Contrast Media; Echocardiography, Doppler; Fabry Disease; Female; Fluorodeoxyglucose F18; Gadolinium DTPA; Humans; Magnetic Resonance Imaging; Middle Aged; Multimodal Imaging; Mutation; Positron-Emission Tomography; Radiopharmaceuticals; Sensitivity and Specificity; Troponin; Ventricular Dysfunction, Left | 2018 |
Regional Myocardial Perfusion Disturbance in Experimental Chronic Chagas Cardiomyopathy.
Topics: Animals; Chagas Cardiomyopathy; Chronic Disease; Coronary Circulation; Cricetinae; Disease Models, Animal; Female; Fluorodeoxyglucose F18; Microvessels; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Systole; Tissue Survival; Ventricular Dysfunction, Left | 2018 |
Prognostic value of revascularising viable myocardium in elderly patients with stable coronary artery disease and left ventricular dysfunction: a PET/CT study.
Topics: Aged; Aged, 80 and over; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Myocardial Revascularization; Myocardium; Positron Emission Tomography Computed Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; Retrospective Studies; Ventricular Dysfunction, Left | 2018 |
Systemic sarcoidosis presenting as complete heart block in a patient with normal chest radiography.
Topics: Adult; Aftercare; Defibrillators, Implantable; Diagnosis, Differential; Echocardiography; Fluorodeoxyglucose F18; Glucocorticoids; Heart Block; Humans; Lymph Nodes; Male; Positron Emission Tomography Computed Tomography; Prednisone; Rare Diseases; Sarcoidosis; Spleen; Treatment Outcome; Ventricular Dysfunction, Left | 2019 |
Left Ventricular Remodeling Results in Homogenization of Myocardial Work Distribution.
Topics: Adaptation, Physiological; Animals; Cardiac Pacing, Artificial; Disease Models, Animal; Energy Metabolism; Female; Fluorodeoxyglucose F18; Glucose; Hypertrophy, Left Ventricular; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Sheep, Domestic; Time Factors; Ventricular Dysfunction, Left; Ventricular Function, Left; Ventricular Remodeling | 2019 |
No differences in rest myocardial blood flow in stunned and hibernating myocardium: insights into the pathophysiology of ischemic cardiomyopathy.
Topics: Aged; Cardiomyopathies; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Motion; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardium; Positron-Emission Tomography; Predictive Value of Tests; Retrospective Studies; Ventricular Dysfunction, Left | 2019 |
Identification of therapeutic benefit from revascularization in patients with left ventricular systolic dysfunction: inducible ischemia versus hibernating myocardium.
Topics: Aged; Cardiovascular Agents; Chi-Square Distribution; Female; Fluorodeoxyglucose F18; Hemodynamics; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Revascularization; Myocardial Stunning; Myocardium; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Propensity Score; Proportional Hazards Models; Radiopharmaceuticals; Recovery of Function; Risk Assessment; Risk Factors; Rubidium Radioisotopes; Stroke Volume; Time Factors; Tissue Survival; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2013 |
Identification of inflamed aortic plaque in conventional fluorodeoxyglucose-positron emission tomography myocardial viability studies.
Topics: Aged; Aorta; Coronary Artery Disease; Feasibility Studies; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multimodal Imaging; Plaque, Atherosclerotic; Positron-Emission Tomography; Retrospective Studies; Tissue Survival; Tomography, X-Ray Computed; Ventricular Dysfunction, Left | 2013 |
The amount of dysfunctional but viable myocardium predicts long-term survival in patients with ischemic cardiomyopathy and left ventricular dysfunction.
Topics: Cardiomyopathies; Coronary Artery Bypass; Fluorodeoxyglucose F18; Humans; Kaplan-Meier Estimate; Myocardial Ischemia; Myocardial Perfusion Imaging; Myocardial Stunning; Myocardium; Patient Selection; Percutaneous Coronary Intervention; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Time Factors; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left | 2013 |
The amount of viable and dyssynchronous myocardium is associated with response to cardiac resynchronization therapy: initial clinical results using multiparametric ECG-gated [18F]FDG PET.
Topics: Cardiac Resynchronization Therapy; Cardiac-Gated Imaging Techniques; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Tissue Survival; Treatment Outcome; Ventricular Dysfunction, Left | 2013 |
The impacts of severe perfusion defects, akinetic/dyskinetic segments, and viable myocardium on the accuracy of volumes and LVEF measured by gated ⁹⁹mTc-MIBI SPECT and gated ¹⁸F-FDG PET in patients with left ventricular aneurysm: cardiac magnetic resonanc
Topics: Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left | 2014 |
Left ventricular asynchrony in early isolated cardiac sarcoidosis.
Topics: Adult; Cardiomyopathies; Coronary Angiography; Early Diagnosis; Fluorodeoxyglucose F18; Gadolinium; Glucocorticoids; Humans; Magnetic Resonance Imaging, Cine; Male; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Sarcoidosis; Sensitivity and Specificity; Tomography, X-Ray Computed; Treatment Outcome; Ventricular Dysfunction, Left | 2016 |
The Sodium-Glucose Cotransporter 2 Inhibitor Dapagliflozin Prevents Cardiomyopathy in a Diabetic Lipodystrophic Mouse Model.
Topics: Animals; Benzhydryl Compounds; Blood Glucose; Cardiomyopathy, Hypertrophic; Diabetes Mellitus, Type 2; Diabetic Cardiomyopathies; Disease Models, Animal; Echocardiography; Fluorodeoxyglucose F18; Glucosides; GTP-Binding Protein gamma Subunits; Heart; Heterotrimeric GTP-Binding Proteins; Hyperglycemia; Hypoglycemic Agents; Lipodystrophy; Magnetic Resonance Imaging; Mice; Mice, Knockout; Myocardium; Pioglitazone; Positron-Emission Tomography; Radiopharmaceuticals; Sodium-Glucose Transporter 2 Inhibitors; Thiazolidinediones; Ventricular Dysfunction, Left; Ventricular Function | 2017 |
Prognostic performance of quantitative PET tools for stratification of patients with ischemic cardiomyopathy undergoing myocardial viability assessment.
Topics: Aged; Cardiomyopathies; Coronary Circulation; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Humans; Kaplan-Meier Estimate; Male; Middle Aged; Myocardial Ischemia; Positron-Emission Tomography; Predictive Value of Tests; Prognosis; Radiopharmaceuticals; ROC Curve; Rubidium Radioisotopes; Ventricular Dysfunction, Left | 2008 |
Agreement and disagreement between contrast-enhanced magnetic resonance imaging and nuclear imaging for assessment of myocardial viability.
Topics: Aged; Cardiology; Contrast Media; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2009 |
Relation of brain natriuretic peptide level to extent of left ventricular scarring in patients with chronic heart failure secondary to ischemic cardiomyopathy.
Topics: Aged; Chi-Square Distribution; Cicatrix; Echocardiography; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Natriuretic Peptide, Brain; Radiopharmaceuticals; Regression Analysis; Retrospective Studies; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2009 |
Viable: yes, no, or somewhere in the middle?
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Myocardial Revascularization; Myocardial Stunning; Myocardium; Patient Selection; Positron-Emission Tomography; Predictive Value of Tests; Radiopharmaceuticals; Risk Assessment; Risk Factors; Time Factors; Tissue Survival; Treatment Outcome; Ventricular Dysfunction, Left | 2009 |
Cardiomyopathy of uncertain etiology: Complementary role of multimodality imaging with cardiac MRI and 18FDG PET.
Topics: Arrhythmias, Cardiac; Cardiomyopathies; Coronary Angiography; Coronary Artery Disease; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Middle Aged; Positron-Emission Tomography; Syncope; Tachycardia, Ventricular; Ventricular Dysfunction, Left | 2010 |
Viability assessment with MRI is superior to FDG-PET for viability: Pro.
Topics: Contrast Media; Coronary Artery Disease; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Myocardium; Perfusion; Positron-Emission Tomography; Prognosis; Treatment Outcome; Ventricular Dysfunction, Left | 2010 |
Viability assessment with MRI is superior to FDG-PET for viability: Con.
Topics: Contrast Media; Coronary Artery Disease; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Models, Anatomic; Myocardium; Positron-Emission Tomography; Reproducibility of Results; ROC Curve; Treatment Outcome; Ventricular Dysfunction, Left | 2010 |
18F-FDG PET imaging of myocardial viability in an experienced center with access to 18F-FDG and integration with clinical management teams: the Ottawa-FIVE substudy of the PARR 2 trial.
Topics: Canada; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Revascularization; Patient Care Team; Positron-Emission Tomography; Professional Competence; Radiopharmaceuticals; Randomized Controlled Trials as Topic; Survival Analysis; Tissue Survival; Ventricular Dysfunction, Left | 2010 |
Diabetic cardiomyopathy in Zucker diabetic fatty rats: the forgotten right ventricle.
Topics: Animals; Blood Glucose; Cardiomyopathies; Diabetes Mellitus, Type 2; Disease Models, Animal; Dyslipidemias; Echocardiography, Doppler; Fatty Acids; Fluorodeoxyglucose F18; Glucose Clamp Technique; Heart Ventricles; Hyperinsulinism; Insulin; Male; Phosphorylation; Positron-Emission Tomography; Proto-Oncogene Proteins c-akt; Radiopharmaceuticals; Rats; Rats, Zucker; Triglycerides; Ventricular Dysfunction, Left; Ventricular Dysfunction, Right; Ventricular Function, Left; Ventricular Function, Right | 2010 |
Assessment of left ventricular volumes, ejection fraction and mass. Comparison of model-based analysis of ECG-gated (⁹⁹m)Tc-SPECT and ¹⁸F-FDG-PET.
Topics: Cardiac-Gated Imaging Techniques; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organ Size; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Stroke Volume; Technetium; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2011 |
Altered myocardial glucose utilization and the reverse mismatch pattern on rubidium-82 perfusion/F-18-FDG PET during the sub-acute phase following reperfusion of acute anterior myocardial infarction.
Topics: Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Positron-Emission Tomography; Prospective Studies; Radiopharmaceuticals; Rubidium Radioisotopes; Ventricular Dysfunction, Left | 2011 |
Left ventricular dyssynchrony assessment by phase analysis from gated PET-FDG scans.
Topics: Adult; Aged; Aged, 80 and over; Cardiac Resynchronization Therapy; Coronary Artery Bypass; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Perfusion Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2011 |
Similar patterns of myocardial metabolism and perfusion in patients with type 2 diabetes and heart disease of ischaemic and non-ischaemic origin.
Topics: Aged; Coronary Artery Disease; Coronary Circulation; Cross-Sectional Studies; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Humans; Insulin Resistance; Male; Myocardial Ischemia; Positron-Emission Tomography; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2012 |
Comparison of nitrate augmented Tc-99m tetrofosmin gated SPECT imaging with FDG PET imaging for the assessment of myocardial viability in patients with severe left ventricular dysfunction.
Topics: Adult; Aged; Cardiac-Gated Single-Photon Emission Computer-Assisted Tomography; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Infarction; Nitrates; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2012 |
Relationship between mechanical and metabolic dyssynchrony with left bundle branch block: evaluation by 18-fluorodeoxyglucose positron emission tomography in patients with non-ischemic heart failure.
Topics: Adult; Aged; Bundle-Branch Block; Case-Control Studies; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucose; Heart Failure; Humans; Male; Middle Aged; Positron-Emission Tomography; Stroke Volume; Ventricular Dysfunction, Left | 2012 |
Scar imaging using multislice computed tomography versus metabolic imaging by F-18 FDG positron emission tomography: a pilot study.
Topics: Aged; Cicatrix; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Multidetector Computed Tomography; Pilot Projects; Positron-Emission Tomography; Prospective Studies; Ventricular Dysfunction, Left | 2013 |
Comparison of (99m)Tc-MIBI SPECT/18F-FDG PET imaging and cardiac magnetic resonance imaging in patients with idiopathic dilated cardiomyopathy: assessment of cardiac function and myocardial injury.
Topics: Cardiomyopathy, Dilated; Contrast Media; Coronary Circulation; Diagnostic Imaging; Female; Fluorodeoxyglucose F18; Gadolinium; Heart; Heart Injuries; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Positron-Emission Tomography; Retrospective Studies; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Young Adult | 2012 |
Phase analysis by gated F-18 FDG PET/CT for left ventricular dyssynchrony assessment: a comparison with gated Tc-99m sestamibi SPECT.
Topics: Algorithms; Cardiac-Gated Imaging Techniques; Coronary Artery Disease; Fluorodeoxyglucose F18; Humans; Image Enhancement; Image Interpretation, Computer-Assisted; Male; Middle Aged; Multimodal Imaging; Positron-Emission Tomography; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Software; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Tomography, X-Ray Computed; Ventricular Dysfunction, Left | 2013 |
Prevalence of myocardial viability assessed by single photon emission computed tomography in patients with chronic ischaemic left ventricular dysfunction.
Topics: Coronary Circulation; Coronary Vessels; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Comparison of positron emission tomography with the resting electrocardiogram for assessing viable myocardium in chronic ischemic cardiomyopathy involving the anterior left ventricular wall.
Topics: Aged; Chronic Disease; Coronary Angiography; Electrocardiography; Energy Metabolism; Female; Fluorodeoxyglucose F18; Heart Aneurysm; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Ischemia; Myocardium; Necrosis; Predictive Value of Tests; Prognosis; Tissue Survival; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2002 |
Gated 99mTc-tetrofosmin and 18F-FDG studies: a comparison of single-acquisition and separate-acquisition protocols.
Topics: Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Humans; Organophosphorus Compounds; Organotechnetium Compounds; Prospective Studies; Radiopharmaceuticals; Single-Blind Method; Statistics as Topic; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Evidence of reverse mismatch with positron emission tomography imaging in a patient with reversible myocardial dysfunction.
Topics: Female; Fluorodeoxyglucose F18; Humans; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardium; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2002 |
Assessment of myocardial viability using coronary zero flow pressure after successful angioplasty in patients with acute anterior myocardial infarction.
Topics: Aged; Angioplasty, Balloon; Blood Flow Velocity; Coronary Angiography; Coronary Circulation; Coronary Stenosis; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Prospective Studies; Radiopharmaceuticals; Thrombolytic Therapy; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Prediction of left ventricular functional recovery by dobutamine echocardiography, F-18 deoxyglucose or 99mTc sestamibi nuclear imaging in patients with chronic myocardial infarction.
Topics: Aged; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Revascularization; Predictive Value of Tests; Prospective Studies; Radiopharmaceuticals; Recovery of Function; Reproducibility of Results; ROC Curve; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Nuclear imaging is more sensitive for the detection of viable myocardium than dobutamine echocardiography.
Topics: Coronary Artery Disease; Dobutamine; Echocardiography; Fatty Acids; Fluorodeoxyglucose F18; Glucose; Heart Ventricles; Humans; Iodobenzenes; Middle Aged; Myocardium; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Thallium; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
125I-BMIPP and 18F-FDG uptake in a transgenic mouse model of stunned myocardium.
Topics: Animals; Coronary Circulation; Fasting; Fatty Acids; Fluorodeoxyglucose F18; Glucose; Iodobenzenes; Mice; Mice, Transgenic; Myocardial Stunning; Radionuclide Imaging; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left | 2003 |
Post-extrasystolic potentiation recruits incremental contractile reserve of dyssynergic myocardium during dobutamine stress testing: evidence by pulsed wave tissue Doppler imaging.
Topics: Aged; Cardiac Complexes, Premature; Echocardiography, Doppler, Pulsed; Echocardiography, Stress; Fluorodeoxyglucose F18; Humans; Male; Myocardial Contraction; Myocardium; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Detection of scarred and viable myocardium using a new magnetic resonance imaging technique: blood oxygen level dependent (BOLD) MRI.
Topics: Aged; Cicatrix; Coronary Artery Bypass; Coronary Stenosis; Female; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardial Revascularization; Myocardial Stunning; Postoperative Care; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 2003 |
Preoperative comparison of different noninvasive strategies for predicting improvement in left ventricular function after coronary artery bypass grafting.
Topics: Aged; Coronary Artery Bypass; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Postoperative Period; Predictive Value of Tests; Radionuclide Ventriculography; Radiopharmaceuticals; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Dobutamine magnetic resonance imaging predicts contractile reserve of chronically dysfunctional myocardium: comparison with was fluorine-18 fluorodeoxyglucose positron emission tomography.
Topics: Adult; Aged; Cardiotonic Agents; Dobutamine; Female; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Radiopharmaceuticals; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2000 |
Relation between QT dispersion and myocardial viability in ischemic cardiomyopathy.
Topics: Aged; Cardiomyopathies; Coronary Artery Disease; Electrocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Predictive Value of Tests; Radiopharmaceuticals; Severity of Illness Index; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2003 |
Myocardial perfusion and glucose uptake coupling in CAD patients.
Topics: Adult; Aged; Biomarkers; Blood Glucose; Coronary Artery Disease; Dipyridamole; Fatty Acids, Nonesterified; Female; Fluorodeoxyglucose F18; Glucose Clamp Technique; Humans; Hyperinsulinism; Male; Middle Aged; Myocardial Reperfusion; Myocardium; Radiopharmaceuticals; Rest; Severity of Illness Index; Statistics as Topic; Stroke Volume; Tomography, Emission-Computed; Vasodilator Agents; Ventricular Dysfunction, Left | 2003 |
Myocardial positron emission computed tomographic images obtained with fluorine-18 fluoro-2-deoxyglucose predict the response of idiopathic dilated cardiomyopathy patients to beta-blockers.
Topics: Adrenergic beta-Antagonists; Adult; Cardiomyopathy, Dilated; Female; Fluorodeoxyglucose F18; Heart Function Tests; Humans; Male; Middle Aged; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 2004 |
The natural history of myocardium awaiting revascularisation in patients with impaired left ventricular function.
Topics: Coronary Artery Bypass; Coronary Circulation; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Myocardial Infarction; Myocardial Revascularization; Myocardium; Postoperative Care; Prospective Studies; Radiopharmaceuticals; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2004 |
Pulsed wave tissue Doppler imaging for the quantification of contractile reserve in stunned, hibernating, and scarred myocardium.
Topics: Cicatrix; Coronary Disease; Diagnosis, Differential; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Stunning; Organophosphorus Compounds; Organotechnetium Compounds; Radiopharmaceuticals; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2004 |
PET abnormalities in patients with nonischemic cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Retrospective Studies; Rubidium Radioisotopes; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2004 |
Assessment of myocardial viability by nuclear imaging techniques.
Topics: Animals; Cardiomyopathies; Diabetes Complications; Disease Models, Animal; Echocardiography, Stress; Fluorodeoxyglucose F18; Heart; Humans; Myocardial Contraction; Myocardial Ischemia; Myocardial Revascularization; Myocardial Stunning; Positron-Emission Tomography; Prognosis; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Sensitivity and Specificity; Stroke Volume; Swine; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2005 |
Quantitative analysis of myocardial glucose utilization in patients with left ventricular dysfunction by means of 18F-FDG dynamic positron tomography and three-compartment analysis.
Topics: Aged; Biological Transport; Blood Glucose; Female; Fluorodeoxyglucose F18; Glucose; Heart Ventricles; Humans; Kinetics; Male; Middle Aged; Myocardium; Perfusion; Positron-Emission Tomography; Radiopharmaceuticals; Time Factors; Ventricular Dysfunction, Left | 2005 |
Post-systolic shortening during dobutamine stress echocardiography predicts cardiac survival in patients with severe left ventricular dysfunction.
Topics: Cardiomyopathies; Coronary Artery Bypass; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardium; Netherlands; Prognosis; Prospective Studies; Radiopharmaceuticals; Stroke Volume; Survival Analysis; Systole; Tissue Survival; Tomography, Emission-Computed, Single-Photon; Ultrasonography, Doppler, Pulsed; Ventricular Dysfunction, Left | 2005 |
Strain rate analysis allows detection of differences in diastolic function between viable and nonviable myocardial segments.
Topics: Analysis of Variance; Cardiotonic Agents; Chi-Square Distribution; Coronary Angiography; Diastole; Dobutamine; Echocardiography; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Contraction; Radiopharmaceuticals; Reproducibility of Results; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2005 |
Myocardial technetium-99m-tetrofosmin single-photon emission computed tomography compared with 18F-fluorodeoxyglucose imaging to assess myocardial viability.
Topics: Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Organophosphorus Compounds; Organotechnetium Compounds; Predictive Value of Tests; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2005 |
FDG imaging should be considered the preferred technique for accurate assessment of myocardial viability: against.
Topics: Coronary Artery Disease; Fluorodeoxyglucose F18; Heart Diseases; Humans; Image Processing, Computer-Assisted; Ischemia; Myocardium; Perfusion; Radiography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2005 |
Myocardial perfusion/metabolism mismatch and ventricular arrhythmias in the chronic post infarction state.
Topics: Coronary Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Reperfusion; Myocardium; Organophosphorus Compounds; Organotechnetium Compounds; Positron-Emission Tomography; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Fibrillation | 2005 |
[Comparative study of 18 F-fluorodeoxyglucose imaging with a dual-head coincidence gamma camera with dobutamine stress echocardiography for the assessment of myocardial viability].
Topics: Echocardiography, Stress; Epidemiologic Methods; Female; Fluorodeoxyglucose F18; Gamma Cameras; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Revascularization; Radiopharmaceuticals; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2005 |
Monitoring left ventricular dilation in mice with PET.
Topics: Aging; Algorithms; Animals; Cardiomyopathy, Dilated; Fluorodeoxyglucose F18; Image Interpretation, Computer-Assisted; Imaging, Three-Dimensional; Mice; Positron-Emission Tomography; Radiopharmaceuticals; Severity of Illness Index; Ventricular Dysfunction, Left | 2005 |
The extent of perfusion-F18-fluorodeoxyglucose positron emission tomography mismatch determines mortality in medically treated patients with chronic ischemic left ventricular dysfunction.
Topics: Aged; Chronic Disease; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Myocardial Ischemia; Positron-Emission Tomography; Prognosis; Prospective Studies; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2005 |
Myocardial viability testing and the effect of early intervention in patients with advanced left ventricular systolic dysfunction.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Positron-Emission Tomography; Survival Analysis; Systole; Tissue Survival; Ventricular Dysfunction, Left | 2006 |
Evaluation of myocardial glucose metabolism before and after recovery of myocardial function in patients with tachycardia-induced cardiomyopathy.
Topics: Cardiomyopathies; Case-Control Studies; Catheter Ablation; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Glucose; Humans; Male; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Recovery of Function; Tachycardia; Ventricular Dysfunction, Left | 2006 |
[Clinical impact of positron emission tomography by coincidence system with 18F-FDG on therapeutic decision-making of patients with ischemic cardiomyopathy after myocardial infarction].
Topics: Decision Making, Computer-Assisted; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart; Heart Ventricles; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Myocardial Revascularization; Positron-Emission Tomography; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left | 2006 |
Takotsubo cardiomyopathy in positron emission tomography.
Topics: Aged; Cardiomyopathies; Electrocardiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Myocardial Stunning; Positron-Emission Tomography; Time Factors; Ventricular Dysfunction, Left | 2006 |
Extent of viability to predict response to cardiac resynchronization therapy in ischemic heart failure patients.
Topics: Aged; Cardiac Pacing, Artificial; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Ischemia; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2006 |
Myocardial glucose transport and utilization in patients with type 2 diabetes mellitus, left ventricular dysfunction, and coronary artery disease.
Topics: Aged; Blotting, Western; Cardiac Output, Low; Coronary Artery Disease; Diabetes Mellitus, Type 2; Fluorodeoxyglucose F18; Glucose; Glucose Transporter Type 4; Humans; Middle Aged; Myocardium; Positron-Emission Tomography; Radiopharmaceuticals; Ventricular Dysfunction, Left | 2006 |
Positron emission tomography myocardial perfusion and glucose metabolism imaging.
Topics: Fluorodeoxyglucose F18; Humans; Quality Assurance, Health Care; Radiopharmaceuticals; Tomography, Emission-Computed, Single-Photon; United States; Ventricular Dysfunction, Left | 2006 |
Myocardial pre-synaptic sympathetic function correlates with glucose uptake in the failing human heart.
Topics: Aged; Coronary Angiography; Coronary Artery Disease; Fluorodeoxyglucose F18; Glucose; Heart; Heart Failure; Humans; Insulin Resistance; Magnetic Resonance Imaging; Male; Middle Aged; Myocardium; Myocytes, Cardiac; Norepinephrine; Positron-Emission Tomography; Sensitivity and Specificity; Ventricular Dysfunction, Left | 2007 |
Myocardial viability by contrast-enhanced cardiovascular magnetic resonance in patients with coronary artery disease: comparison with gated single-photon emission tomography and FDG position emission tomography.
Topics: Aged; Analysis of Variance; Chi-Square Distribution; Contrast Media; Coronary Disease; Female; Fluorodeoxyglucose F18; Humans; Image Interpretation, Computer-Assisted; Magnetic Resonance Imaging, Cine; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2007 |
Multi-modality imaging for assessment of myocardial viability?
Topics: Contrast Media; Coronary Disease; Fluorodeoxyglucose F18; Humans; Magnetic Resonance Imaging, Cine; Myocardium; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2007 |
Comparison of contrast-enhanced MRI with (18)F-FDG PET/201Tl SPECT in dysfunctional myocardium: relation to early functional outcome after surgical revascularization in chronic ischemic heart disease.
Topics: Aged; Chronic Disease; Contrast Media; Coronary Artery Bypass; Coronary Artery Disease; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Revascularization; Positron-Emission Tomography; Radiopharmaceuticals; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 2007 |
Relation between dobutamine trans-thoracic echocardiography, 99Tcm-MIBI and 18FDG uptake in chronic coronary artery disease.
Topics: Adult; Aged; Chronic Disease; Contrast Media; Coronary Disease; Deoxyglucose; Dobutamine; Echocardiography; Exercise Test; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Radionuclide Imaging; Technetium Tc 99m Sestamibi; Ventricular Dysfunction, Left | 1995 |
Identification of hibernating myocardium: a comparison between dobutamine echocardiography and study of perfusion and metabolism in patients with severe left ventricular dysfunction.
Topics: Coronary Disease; Deoxyglucose; Dobutamine; Echocardiography; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardium; Reproducibility of Results; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1995 |
Prognosis of patients with left ventricular dysfunction, with and without viable myocardium after myocardial infarction. Relative efficacy of medical therapy and revascularization.
Topics: Aged; Deoxyglucose; Female; Fluorodeoxyglucose F18; Heart; Heart Diseases; Humans; Male; Middle Aged; Myocardial Infarction; Myocardial Revascularization; Prognosis; Survival Analysis; Ventricular Dysfunction, Left | 1994 |
Quantitative relation between myocardial viability and improvement in heart failure symptoms after revascularization in patients with ischemic cardiomyopathy.
Topics: Aged; Ammonia; Coronary Artery Bypass; Coronary Disease; Deoxyglucose; Exercise Tolerance; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Male; Myocardium; Nitrogen Radioisotopes; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1995 |
Clinical importance of viability assessment in chronic ischemic heart failure.
Topics: Chronic Disease; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Retrospective Studies; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 1996 |
Myocardial blood flow, glucose uptake, and recruitment of inotropic reserve in chronic left ventricular ischemic dysfunction. Implications for the pathophysiology of chronic myocardial hibernation.
Topics: Adult; Aged; Ammonia; Carbon Isotopes; Chronic Disease; Coronary Artery Bypass; Coronary Circulation; Coronary Disease; Deoxyglucose; Dobutamine; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Glucose; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Ischemia; Myocardium; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1996 |
Recovery of regional left ventricular dysfunction after coronary revascularization. Impact of myocardial viability assessed by nuclear imaging and vessel patency at follow-up angiography.
Topics: Aged; Cell Survival; Coronary Angiography; Coronary Artery Bypass; Deoxyglucose; Diagnostic Imaging; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Postoperative Period; Predictive Value of Tests; Sensitivity and Specificity; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1996 |
Course of impaired left ventricular function after acute myocardial infarction predicted with planar thallium-201 chloride and F18-fluorodeoxyglucose imaging.
Topics: Deoxyglucose; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Infarction; Prognosis; Radionuclide Imaging; Reproducibility of Results; Thallium; Thallium Radioisotopes; Ventricular Dysfunction, Left | 1996 |
F-18-fluorodeoxyglucose PET imaging alters clinical decision making in patients with impaired ventricular function.
Topics: Aged; Coronary Disease; Decision Making; Deoxyglucose; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Revascularization; Myocardium; Prospective Studies; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1997 |
Relation between contractile reserve and positron emission tomographic patterns of perfusion and glucose utilization in chronic ischemic left ventricular dysfunction: implications for identification of myocardial viability.
Topics: Dobutamine; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Glucose Clamp Technique; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Stunning; Myocardium; Potassium Radioisotopes; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1997 |
Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease.
Topics: Ammonia; Coronary Artery Bypass; Coronary Disease; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Hospital Mortality; Humans; Male; Middle Aged; Myocardial Stunning; Nitrogen Radioisotopes; Patient Selection; Postoperative Complications; Radiopharmaceuticals; Retrospective Studies; Risk Factors; Survival Rate; Time Factors; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1997 |
Steps forward in the assessment of myocardial viability in left ventricular dysfunction.
Topics: Coronary Disease; Fluorodeoxyglucose F18; Humans; Myocardium; Radiopharmaceuticals; ROC Curve; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1998 |
[18F]fluorodeoxyglucose single photon emission computed tomography: can it replace PET and thallium SPECT for the assessment of myocardial viability?
Topics: Adult; Aged; Coronary Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Stroke Volume; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1998 |
Coronary artery bypass surgery as treatment for ischemic heart failure: the predictive value of viability assessment with quantitative positron emission tomography for symptomatic and functional outcome.
Topics: Angina Pectoris; Case-Control Studies; Coronary Artery Bypass; Exercise Test; Exercise Tolerance; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Follow-Up Studies; Heart; Heart Failure; Humans; Male; Middle Aged; Myocardial Stunning; Predictive Value of Tests; Quality of Life; Radiopharmaceuticals; ROC Curve; Time Factors; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
Fluorodeoxyglucose uptake in dysfunctional myocardium subtended by an occluded coronary artery. Relation to dobutamine contractile reserve and Sestamibi uptake.
Topics: Adult; Aged; Cardiotonic Agents; Coronary Disease; Dobutamine; Echocardiography; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Contraction; Myocardium; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1998 |
Coronary revascularization in the treatment of moderate and severe postischemic left ventricular dysfunction.
Topics: Adult; Aged; Animals; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardial Ischemia; Myocardial Revascularization; Predictive Value of Tests; Radionuclide Ventriculography; Radiopharmaceuticals; Severity of Illness Index; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left | 1998 |
Ischemia and left ventricular dysfunction: a reciprocal relation?
Topics: Adult; Blood Flow Velocity; Coronary Disease; Dipyridamole; Female; Fluorodeoxyglucose F18; Heart Failure; Humans; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Platelet Aggregation Inhibitors; Radiopharmaceuticals; Ventricular Dysfunction, Left | 1998 |
Significance of rest technetium-99m sestamibi imaging for the prediction of improvement of left ventricular dysfunction after Q wave myocardial infarction: importance of infarct location adjusted thresholds.
Topics: Aged; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Contraction; Myocardial Infarction; Myocardial Revascularization; Postoperative Complications; Prognosis; Stroke Volume; Technetium Tc 99m Sestamibi; Tissue Survival; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1998 |
Comparison of fluorine-18-FDG with rest-redistribution thallium-201 SPECT to delineate viable myocardium and predict functional recovery after revascularization.
Topics: Aged; Angioplasty, Balloon, Coronary; Coronary Artery Bypass; Echocardiography; Female; Fluorine Radioisotopes; Fluorodeoxyglucose F18; Heart; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Stunning; Predictive Value of Tests; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Thallium Radioisotopes; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1998 |
Assessment of myocardial viability with MR--the Cologne perspective.
Topics: Echocardiography, Transesophageal; Fluorodeoxyglucose F18; Heart; Humans; Magnetic Resonance Imaging; Myocardial Infarction; Myocardium; Tissue Survival; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1998 |
Thallium scintigraphy compared with 18F-fluorodeoxyglucose positron emission tomography for assessing myocardial viability in patients with moderate versus severe left ventricular dysfunction.
Topics: Aged; Exercise Test; Female; Fluorodeoxyglucose F18; Heart; Humans; Male; Middle Aged; Myocardial Stunning; Predictive Value of Tests; Radiopharmaceuticals; Regional Blood Flow; Thallium Radioisotopes; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1998 |
Delay in revascularization is associated with increased mortality rate in patients with severe left ventricular dysfunction and viable myocardium on fluorine 18-fluorodeoxyglucose positron emission tomography imaging.
Topics: Aged; Female; Fluorodeoxyglucose F18; Heart; Heart Transplantation; Humans; Male; Middle Aged; Myocardial Revascularization; Patient Selection; Survival Analysis; Tissue Survival; Tomography, Emission-Computed; Treatment Outcome; Ventricular Dysfunction, Left; Ventricular Function, Left; Waiting Lists | 1998 |
13N-ammonia myocardial blood flow and uptake: relation to functional outcome of asynergic regions after revascularization.
Topics: Adult; Aged; Ammonia; Blood Flow Velocity; Coronary Circulation; Coronary Disease; Female; Fluorodeoxyglucose F18; Gated Blood-Pool Imaging; Heart Ventricles; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Revascularization; Nitrogen Radioisotopes; ROC Curve; Stroke Volume; Thallium Radioisotopes; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Treatment Outcome; Ventricular Dysfunction, Left | 1999 |
Functional status and quality of life in patients with heart failure undergoing coronary bypass surgery after assessment of myocardial viability.
Topics: Aged; Cardiotonic Agents; Coronary Artery Bypass; Dobutamine; Echocardiography; Exercise Test; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Failure; Humans; Male; Myocardial Ischemia; Prognosis; Prospective Studies; Quality of Life; Radiopharmaceuticals; ROC Curve; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Dysfunction, Left; Ventricular Function, Left | 1999 |
Blood flow-metabolism imaging with positron emission tomography in patients with diabetes mellitus for the assessment of reversible left ventricular contractile dysfunction.
Topics: Aged; Aged, 80 and over; Blood Flow Velocity; Blood Glucose; Coronary Circulation; Coronary Disease; Diabetes Mellitus; Echocardiography; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Heart Ventricles; Humans; Insulin; Male; Middle Aged; Myocardial Contraction; Myocardial Revascularization; Prognosis; Radiopharmaceuticals; Reproducibility of Results; Retrospective Studies; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1999 |
Assessment of CABG-related risk in patients with CAD and LVD. Contribution of PET with [18F]FDG to the assessment of myocardial viability.
Topics: Coronary Artery Bypass; Coronary Disease; Decision Making; Female; Fluorodeoxyglucose F18; Follow-Up Studies; Humans; Male; Middle Aged; Myocardial Stunning; Proportional Hazards Models; Radiopharmaceuticals; Retrospective Studies; Risk Assessment; Survival Rate; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 1999 |
Fluorodeoxyglucose imaging to assess myocardial viability: PET, SPECT or gamma camera coincidence imaging?
Topics: Fluorine Radioisotopes; Fluorodeoxyglucose F18; Gamma Cameras; Heart; Humans; Myocardial Ischemia; Myocardial Stunning; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 1999 |
Lack of prognostic value of 99mTc MIBI rest, 18F FDG and 201TL rest/redistribution on PTCA outcome of patients with moderate left ventricle dysfunction.
Topics: Adult; Aged; Angioplasty, Balloon, Coronary; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Prognosis; Radiopharmaceuticals; Technetium Tc 99m Sestamibi; Thallium Radioisotopes; Treatment Outcome; Ventricular Dysfunction, Left | 1999 |
Regional myocardial blood flow reserve impairment and metabolic changes suggesting myocardial ischemia in patients with idiopathic dilated cardiomyopathy.
Topics: Adult; Aged; Cardiomyopathy, Dilated; Coronary Circulation; Dipyridamole; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Hyperemia; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Ischemia; Oxygen Consumption; Reference Values; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2000 |
Doppler tissue velocity sampling improves diagnostic accuracy during dobutamine stress echocardiography for the assessment of viable myocardium in patients with severe left ventricular dysfunction.
Topics: Dobutamine; Echocardiography, Doppler, Pulsed; Exercise Test; Female; Fluorodeoxyglucose F18; Humans; Infusions, Intravenous; Male; Middle Aged; Myocardial Contraction; Observer Variation; Radiopharmaceuticals; Reproducibility of Results; Sensitivity and Specificity; Severity of Illness Index; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2000 |
Utility of positron emission tomography in predicting cardiac events and survival in patients with coronary artery disease and severe left ventricular dysfunction.
Topics: Aged; Coronary Disease; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Nitrogen Radioisotopes; Predictive Value of Tests; Radiopharmaceuticals; Retrospective Studies; Survival Rate; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2001 |
Is chronically dysfunctional yet viable myocardium distal to a severe coronary stenosis hypoperfused?
Topics: Animals; Coronary Circulation; Echocardiography; Fluorodeoxyglucose F18; Male; Myocardial Infarction; Myocardial Stunning; Myocardium; Radionuclide Imaging; Swine; Swine, Miniature; Tissue Survival; Ventricular Dysfunction, Left | 2001 |
Improved identification of viable myocardium using second harmonic imaging during dobutamine stress echocardiography.
Topics: Cardiotonic Agents; Dobutamine; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Humans; Male; Middle Aged; Myocardium; Radiopharmaceuticals; Sensitivity and Specificity; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2001 |
Myocardial glucose utilization and optimization of (18)F-FDG PET imaging in patients with non-insulin-dependent diabetes mellitus, coronary artery disease, and left ventricular dysfunction.
Topics: Coronary Artery Disease; Diabetes Mellitus, Type 2; Female; Fluorodeoxyglucose F18; Glucose; Glucose Clamp Technique; Glucose Tolerance Test; Humans; Image Enhancement; Male; Middle Aged; Myocardium; Niacin; Radiopharmaceuticals; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2001 |
Strain rate measurement by doppler echocardiography allows improved assessment of myocardial viability inpatients with depressed left ventricular function.
Topics: Aged; Coronary Stenosis; Dobutamine; Echocardiography, Doppler; Echocardiography, Stress; Female; Fluorodeoxyglucose F18; Heart; Humans; Image Enhancement; Male; Middle Aged; Myocardium; Predictive Value of Tests; Reproducibility of Results; ROC Curve; Sampling Studies; Sensitivity and Specificity; Tomography, Emission-Computed; Ventricular Dysfunction, Left | 2002 |
QT dispersion and viable myocardium in patients with prior myocardial infarction and severe left ventricular dysfunction.
Topics: Aged; Female; Fluorodeoxyglucose F18; Humans; Image Processing, Computer-Assisted; Male; Middle Aged; Myocardial Infarction; Prospective Studies; Stroke Volume; Technetium Tc 99m Sestamibi; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
Assessment of viable tissue in Q-wave regions by metabolic imaging using single-photon emission computed tomography in ischemic cardiomyopathy.
Topics: Aged; Cardiomyopathies; Echocardiography; Electrocardiography; Female; Fluorodeoxyglucose F18; Heart Ventricles; Humans; Image Enhancement; Male; Middle Aged; Myocardial Ischemia; Radiopharmaceuticals; Stroke Volume; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left | 2002 |
[Evaluation of myocardial viability with contrast-enhanced magnetic resonance imaging--comparison of the late enhancement technique with positronemission tomography].
Topics: Aged; Coronary Circulation; Energy Metabolism; Female; Fluorodeoxyglucose F18; Humans; Image Enhancement; Magnetic Resonance Imaging; Male; Middle Aged; Myocardial Infarction; Myocardial Ischemia; Reproducibility of Results; Tissue Survival; Tomography, Emission-Computed; Tomography, Emission-Computed, Single-Photon; Ventricular Dysfunction, Left; Ventricular Function, Left | 2002 |